Glaxo Smith Klyne could be one of the parties seeking an interest in PTD.
They recently acquired Domantis and PTD's share as well.
Not unreasonable to consider GSK are a potential suitor of PTD.
PTD mentioned today the companies were Top Tier and global and industry specified firms.